PeptidesRx Review
PeptidesRx is no longer available as we reviewed it, so this page is kept for reference.
PeptidesRx: Site says it is temporarily closed and under construction. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →PeptidesRx, which traded as GetPeptidesRx, was a Fort Worth, Texas telehealth platform that sold compounded semaglutide and tirzepatide alongside prescription peptides such as BPC-157 and PT-141. Its site now shows only a notice that it is temporarily closed and under construction, so there is no way to sign up, order or check prices.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to PeptidesRx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
PeptidesRx at a glance
- Type
- GLP-1 telehealth provider
- FDA status
- No FDA warning letter on record
How we scored PeptidesRx
Each dimension is scored algorithmically from PeptidesRx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.2/10PeptidesRx no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
6.6/10PeptidesRx's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence, so weigh the clinical support carefully.
User Experience15%
8.0/10Online intake and platform experience; 2 platform features disclosed.
Trust & Safety15%
8.1/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.2/10PeptidesRx's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
7.0/10PeptidesRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this PeptidesRx review
Last checked August 2026- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What we like
- Review page kept live so former patients get a straight answer
Watch-outs
- Site says it is temporarily closed, so there is no way to sign up or reorder
- No reopening date or patient instructions beyond a support email address
PeptidesRx says it is temporarily closed
If you came here looking for PeptidesRx's compounded semaglutide and tirzepatide, you can't order them right now. The PeptidesRx storefront (it traded as GetPeptidesRx) shows a single notice saying the site is temporarily closed and under construction, with a support email address for questions. There is no catalog, no price list and no sign-up behind it, and the notice has been up since at least August 2026.
When it was open, PeptidesRx was a Fort Worth, Texas telehealth platform that sold compounded GLP-1s alongside prescription peptides such as BPC-157 and PT-141, and it pitched itself as a licensed alternative to research-chemical sellers. The notice says it will be back, but gives no date, so we treat it as closed until it reopens with a working shop.
What to do if you were a patient
Talk with a prescriber before your current supply runs out. A GLP-1 dose should be continued or adjusted on clinical advice, not interrupted because a seller paused trading, and restarting at a high dose after a gap can be unsafe. If your medication label names a pharmacy, keep that information handy, because the dispensing pharmacy is a separate business from the platform that arranged your visit. The support email on the closure notice is the only published contact.
Where to look instead
The alternatives listed on this page are all currently operating and carry current prices. You can also start from our semaglutide provider rankings and compare what each provider includes as well as what it charges, using the factors in our scoring methodology.
Bottom line
PeptidesRx is not selling anything right now. We keep this page up so people searching for it get a clear answer rather than a dead link. It is excluded from our rankings and carries no outbound link.
The Bottom Line
PeptidesRx is no longer available as we reviewed it, so this page is kept for reference.
PeptidesRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this PeptidesRx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.